DN
Dr. Nurulain T. Zaveri, PhD, FAAPS
Founder, President, and Chief Scientific Officer
Astraea TherapeuticsTherapeutic Areas
Astraea Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| AT-121 | Smoking Cessation / Abstinence; Pain | Phase 1 |
Founder, President, and Chief Scientific Officer
Astraea Therapeutics| Drug | Indication | Phase |
|---|---|---|
| AT-121 | Smoking Cessation / Abstinence; Pain | Phase 1 |